Methodology of a phase 2, randomized, double-blind, placebo-controlled, parallel group, dose-ranging, 36-week, multicenter trial to evaluate the efficacy and safety of daxibotulinumtoxinA for injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury
TOXICON(2018)
关键词
Botulinum toxin,DaxibotulinumtoxinA for injection,RT002,Stroke,Traumatic brain injury,Upper limb spasticity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要